# FDA Inspection 1162450 - Gulbrandsen Technologies Inc - February 16, 2022

Source: https://www.keypedia.com/records/fda_inspections/gulbrandsen-technologies-inc/c66a2f54-57a9-4965-9968-d792d5880f34
Source feed: FDA_Inspections

> FDA Inspection 1162450 for Gulbrandsen Technologies Inc on February 16, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1162450
- Company Name: Gulbrandsen Technologies Inc
- Inspection Date: 2022-02-16
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 940151 - 2015-08-26](https://www.keypedia.com/records/fda_inspections/gulbrandsen-technologies-inc/d3ff4fe3-1b36-4d48-ab04-f6528d559872)

Company: https://www.keypedia.com/companies/gulbrandsen-technologies-inc/1a94e52e-c026-4b40-8cfd-66ea3c4ba645

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c